Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone

The patients with multisystem and risk organ involvement Langerhans cell histiocytosis (MS-RO  + LCH) have poor prognosis. The patients with MS-LCH who failed front-line therapy have a high mortality rate and t...

Source: BMC Pediatrics - January 3, 2024 Category: Pediatrics Authors: Wenqian Wang, Jian Ge, Honghao Ma, Hongyun Lian, Lei Cui, Yunze Zhao, Zhigang Li, Tianyou Wang and Rui Zhang Tags: Research Source Type: research